Avacta to Participate in Conference March 2026
In brief · summary, not quotable
Avacta Group PLC announced that its executive management team will participate in the TD Cowen Health Care Conference in Boston on March 3, 2026. The CEO and CFO will host investor meetings and deliver a live company presentation at 9:10 AM ET, with a replay to be available on the company's investor resources website.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your AVCT notes
| LONDON and PHILADELPHIA - February 18, 2026 - Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre | CISION®, a tumor-activated oncology delivery platform, today announces the executive management team will participate in the TD Cowen Investor Conference in March. |
| Christina Coughlin, CEO and Brian Hahn, CFO of Avacta, will participate in the 46th Annual TD Cowen Health Care Conference in Boston on March 3, 2026. The company will host investor meetings throughout the day, with a live Company presentation at 9:10 AM ET. Investors interested in accessing the Company's presentation may view the replay of the presentation, which will be available after the event on the Investor Resources | Avacta Therapeutics site. |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.